Amgen prevails on appeal in the US patent dispute involving generic psoriasis medications.

Published Date: 22 Apr 2023

On Wednesday, Amgen persuaded a US appeals court to uphold patents that prevented generic versions of its popular psoriasis drug Otezla from being developed by Zydus Pharmaceuticals and Sandoz, a division of Novartis.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.

2.

Study identifies new approach to protect the brain during radiation therapy

3.

While most cancer screenings won't prolong lives, there are still good reasons to continue screening.

4.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

5.

Radiation therapy for patients with breast cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot